Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis. J Am Acad Dermatol. 2006 Apr; 54(4 Suppl 1):S164-70.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Chronic Disease
Female
Humans
Immunologic Factors
Male
Middle Aged
Patient Satisfaction
Psoriasis
Retreatment
Treatment Outcome
authors with profiles
Kenneth Gordon